BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gökçay Canpolat A, Şahin M. Glucose Lowering Treatment Modalities of Type 2 Diabetes Mellitus. Adv Exp Med Biol 2021;1307:7-27. [PMID: 32200500 DOI: 10.1007/5584_2020_516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kornmueller K, Amri E, Scheideler M, Prassl R. Delivery of miRNAs to the adipose organ for metabolic health. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114110] [Reference Citation Analysis]
2 Al Za'abi M, Ali BH, Al Suleimani Y, Adham SA, Ali H, Manoj P, Ashique M, Nemmar A. The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease. Biomolecules 2021;11:814. [PMID: 34070807 DOI: 10.3390/biom11060814] [Reference Citation Analysis]
3 Li Q, Deng X, Jiang N, Meng L, Xing J, Jiang W, Xu Y. Identification and structure-activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Eur J Med Chem 2021;225:113765. [PMID: 34399391 DOI: 10.1016/j.ejmech.2021.113765] [Reference Citation Analysis]
4 Przezak A, Bielka W, Pawlik A. Incretins in the Therapy of Diabetic Kidney Disease. Int J Mol Sci 2021;22:12312. [PMID: 34830194 DOI: 10.3390/ijms222212312] [Reference Citation Analysis]
5 Lunder M, Janić M, Šabovič M. Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs. Int J Mol Sci 2021;22:2796. [PMID: 33801956 DOI: 10.3390/ijms22062796] [Reference Citation Analysis]